• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Screening with digital breast tomosynthesis vs mammography associated with significantly lower risk of advanced breast cancer among women with extremely dense breasts at high risk of breast cancer

byYuchen DaiandMichael Pratte
June 16, 2022
in Chronic Disease, Oncology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Compared to mammography, screening with digital breast tomosynthesis was not associated with a significant difference in risk of interval invasive cancer and associated with a significantly lower risk of advanced breast cancer among women with extremely dense breasts at high risk of breast cancer.

2. No significant difference was observed in women with nondense breasts, heterogeneously dense breasts, or with extremely dense breasts not at high risk.

Evidence Rating Level: 2 (Good)

Study Rundown: Digital breast tomosynthesis (DBT) is a breast imaging modality commonly used in women with dense breasts to help improve cancer detection. Due to a lack of current data, this cohort study evaluated whether DBT vs digital mammography is associated with a lower risk of interval invasive cancer, advanced breast cancer, and false positives among women undergoing routine screening by extent of breast density and breast cancer risk. Key outcomes included rates of interval invasive cancer within 12 months of screening mammography and advanced breast cancer within 12 months of screening mammography. Among 504 427 women screened, interval cancer rates were not significantly different for DBT vs digital mammography. However, in a subset of women with extremely dense breasts and high risk of breast cancer, advanced cancer rates for DBT vs digital mammography were 0.27 vs 0.80 per 1000 examinations, respectively (statistically significant). Among women with nondense breasts, heterogeneously dense breasts, or extremely dense breasts with low to average risk of breast cancer, no significant differences in advanced cancer rates were observed. A limitation of this study was ensuring that risk factors and demographics were comparable for both imaging groups for accurate outcomes assessment.

Click to read the study in JAMA

Click to read an accompanying editorial in JAMA

Relevant Reading: Effectiveness of digital breast tomosynthesis compared with digital mammography: outcomes analysis from 3 years of breast cancer screening

RELATED REPORTS

Alternative Dose Regimens of Exemestane in Postmenopausal Women with Breast Cancer

Combination therapy with alisterib and fulvestrant may be clinically advantageous in the treatment of endocrine-resistant advanced breast cancer

Liver enzymes elevated at 6 months prior to breast cancer liver metastasis detection

In-Depth [prospective cohort]: This cohort study included 504 427 women (median age [IQR], 58 [50-65] years) undergoing screening digital mammography and DBT examinations from 2011-2018 at 44 US Breast Cancer Surveillance Consortium (BCSC) facilities with follow-up through 2019. Overall, interval invasive cancer rates per 1000 examinations were not significantly different for DBT (0.57) vs digital mammography (0.61) (difference, −0.04; 95%CI, −0.14 to 0.06; P = .43) or among patients with low to average risk or high risk across breast density categories. Compared to digital mammography, advanced cancer rates per 1000 examinations were significantly lower for DBT for women with extremely dense breasts at high risk of breast cancer (0.27 vs 0.80; difference, −0.53; 95%CI, −0.97 to −0.10), but not for women at low to average risk (0.54 vs 0.42; difference, 0.12; 95%CI, −0.09 to 0.32).

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Breast Cancerdigital breast tomosynthesismammography
Previous Post

INPULSIS: Nintedanib for Idiopathic Pulmonary Fibrosis [Classics Series]

Next Post

Wellness Check: Spirituality

RelatedReports

Adjuvant radiation decreases local recurrence in low-risk breast cancer
Oncology

Alternative Dose Regimens of Exemestane in Postmenopausal Women with Breast Cancer

March 27, 2023
Preoperative bilateral breast imaging may reduce contralateral cancer recurrence
Chronic Disease

Combination therapy with alisterib and fulvestrant may be clinically advantageous in the treatment of endocrine-resistant advanced breast cancer

March 12, 2023
Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ
Gastroenterology

Liver enzymes elevated at 6 months prior to breast cancer liver metastasis detection

March 8, 2023
#StudyGraphics: Adjuvant abemaciclib improves survival in patients  with hormone receptor-positive early breast cancer
StudyGraphics

#StudyGraphics: Adjuvant abemaciclib improves survival in patients with hormone receptor-positive early breast cancer

March 8, 2023
Next Post

Wellness Check: Spirituality

Interstitial lung abnormalities linked to greater risk of all-cause mortality

Phosphodiesterase 4 inhibitor BI 1015550 preserves lung function in pulmonary fibrosis patients

Novel coronavirus identified from patients with pneumonia in Wuhan, China

High burden of persistent symptoms seen in patients after COVID-19 recovery

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Childhood maltreatment may cause mental health problems
  • #VisualAbstract: Hydrochlorothiazide does not impact risk of kidney-stone recurrence
  • Metformin use may decrease risk of osteoarthritis development
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options